Novavax s COVID Vaccine Found Effective in Final Trial Analysis by Angela Mohan on March 12, 2021 at 2:31 PM
Novavax s COVID-19 shot found to be 96.4% effective against mild, moderate and severe symptoms of COVID-19 in the final analysis of a late-stage trial in the U.K.
The vaccine would be produced at eight locations including the Serum Institute of India, with which Novavax has an agreement to produce around 2 billion doses a year.
The analysis showed the vaccine had 86.3 percent efficacy against the UK variant B.1.1.7/501Y.V1 but it was only 55.4 percent against the South African variant B1.351 among the HIV-negative trial participants, the company said.
Corona: Schwere Erkrankung bei britischer Mutante wahrscheinlicher ksta.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksta.de Daily Mail and Mail on Sunday newspapers.
The Atlantic
The Atlantic Daily: Understanding Long COVID
In the latest issue of our magazine, Meghan O’Rourke surveys what doctors know so far about treating this scary illness and how these studies could transform medicine.
March 9, 2021
For an estimated 10 to 30 percent of COVID-19 patients, recovery can take months. Known as COVID long-haulers, these patients suffer from symptoms such as severe fatigue and brain fog long after their initial infection.
In the latest issue of our magazine, the writer Meghan O’Rourke surveys what doctors know so far about treating this scary illness and explains why long COVID “may change our medical system, our ideas about infectious disease and the future of millions of Americans.”
The Atlantic
Yes, all of the COVID-19 vaccines are very good. No, they’re not all the same.
Adam Maida / Getty / The Atlantic
Public-health officials are enthusiastic about the new, single-shot COVID-19 vaccine from Johnson & Johnson, despite its having a somewhat lower efficacy at preventing symptomatic illness than other available options. Although clinical-trial data peg that rate at 72 percent in the United States, compared with 94 and 95 percent for the Moderna and Pfizer-BioNTech vaccines, many experts say we shouldn’t fixate on those numbers. Much more germane, they say, is the fact that the Johnson & Johnson shot, like the other two, is essentially perfect when it comes to preventing the gravest outcomes. “I’m super-pumped about this,” Virginia’s vaccine coordinator told
Dino Merlin o borbi sa TEŠKOM BOLEŠĆU: „Bio sam kao BILJKA! naslovi.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naslovi.net Daily Mail and Mail on Sunday newspapers.